SOTAC — Sotac Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹1.79bn
- IN₹1.80bn
- IN₹579.83m
- 47
- 15
- 77
- 41
Annual cashflow statement for Sotac Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | 3.58 | -20.6 | 46.9 | 59.6 |
| Depreciation | ||||
| Non-Cash Items | 5.8 | 11.8 | 23 | 7.57 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -22.8 | -20.3 | -17.7 | 1.89 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | 0.57 | -3.07 | 63.5 | 85.4 |
| Capital Expenditures | -98 | -31.6 | -35 | -70.4 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | -19.5 | -0.692 | -0.111 | -38.9 |
| Sale of Fixed Assets | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -117 | -32.3 | -35.2 | -109 |
| Financing Cash Flow Items | 3.99 | -8.16 | -35.4 | 47.6 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 114 | 33.8 | -28.3 | 120 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -2.94 | -1.59 | 0.048 | 95.7 |